Skip to content

2020 Women's Venture Competition

Privo Technologies and its chief executive officer, Manijeh Goldberg, Ph.D., have been selected as the winner of the inaugural AIM-HI Women’s Venture Competition! As a result, Privo Technologies has received investment of $900,000 – $300,000 from AIM-HI and matching investment from two supporters of the Competition!

These funds will serve as seed money for proof of concept and proof of value on the path to clinical trials, and eventually, to new effective therapeutics and diagnostics that will eventually save patients’ lives. Read the Press Release.

Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!

2020 Women’s Venture Competition Winner

Manijeh Goldberg, Ph.D.

CEO, Privo Technologies

Privo Technologies

People’s Choice Award for Best Pitch

María José Alonso

Founder, Libera Bio

Libera Bio

The AIM-HI Accelerator Fund thanks our generous sponsors and dedicated supporters for a fabulous evening on September 24, 2020, celebrating our 8 amazing semi-finalists and their companies at the Awards Ceremony for the inaugural Women’s Venture Competition.

Keynote Speaker

Deepa Narayanan, MS, CCDM

Program Director & Team Leader, SBIR/STTR Programs at National Cancer Institute

We welcome Deepa Narayanan as our Awards Ceremony Keynote Speaker for this exciting event.

Deepa is an experienced professional with expertise in commercialization of innovative healthcare technologies and a  successful background in translation of oncology products to the clinic. Her experience includes non-dilutive funding strategies, portfolio management of oncology startups, identifying technology gaps, technology development, multi-center clinical trials, regulatory approval and market launch, as well as collaborating with key opinion leaders. With a special focus on connecting innovators with high-value funding and non-funding resources, Deepa has over 15 years of experience in academic, commercial and government sectors.

Judging Committee Chairs

Barbara Weber

Barbara Weber, M.D., Chair

President & CEO, Tango Therapeutics

Raju Kucherlapati (1)

Raju Kucherlapati, Ph.D., Co-Chair

Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Selection Committee Chairs

Pamela Garzone

Pamela Garzone, Ph.D., Chair

Chief Medical Officer, Calibr at Scripps Research

Webster Cavenee

Webster Cavenee, Ph.D., Co-chair

Director of Strategic Alliances, Ludwig Institute for Cancer Research

Partner Organizations


Sponsor Organizations

Scripps Research
GoMo Health
BLA Regulatory
Back To Top